A Short-term Mixed Exercise for Sarcopenic Hospitalized Aged 80+ Years

NCT04355299 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 121

Last updated 2020-04-22

No results posted yet for this study

Summary

Most previous clinical trials that addressed exercise for sarcopenic elderly subjects focused on community-dwelling older adults who were relatively healthy. There is a notable paucity of high-quality research investigating the effects and feasibility of exercise for hospitalized or institutionalized older people, who are generally frailer and more severe in functional impairment than those living in the community. Moreover, most reported exercise programs were of long-term duration, which typically lasted 3 to 6 months with two sessions per week. It remains unclear whether short-term exercise would be effective for treating sarcopenia. Therefore, the investigators aimed to assess the effectiveness of short-term exercise for treating sarcopenia in hospitalized older patients aged 80 years and over.

Conditions

Interventions

BEHAVIORAL

balance training

The training to improve balance is to work on the core muscle groups that help to maintain your posture.,and increase muscular strength.

BEHAVIORAL

resistance training

Resistance training is a form of exercise that improves muscular strength and endurance. During a resistance training workout, you move your limbs against resistance provided by your body weight, gravity, bands, weighted bars or dumbbells.

BEHAVIORAL

aerobic exercise

Aerobic exercise is any activity that gets your blood pumping and large muscle groups working. It's also known as cardiovascular activity.

BEHAVIORAL

usual care

received usual care

Sponsors & Collaborators

  • Yuxiang Liang

    lead OTHER

Principal Investigators

  • Jiaojiao Jiang · West China Hospital

  • Ming Yang · West China Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
80 Years
Max Age
102 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-01
Primary Completion
2019-12-30
Completion
2020-01-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04355299 on ClinicalTrials.gov